EU and International Funding Programmes

Horizon Europe: Current Calls
Horizon Europe is the EU-programme for research and innovation for 2021 – 2027. It offers a broad range of funding opportunities, from support for basic scientific research to application-oriented collaborative projects and market launch activities. Open and upcoming calls for Horizon Europe can be found below.
Please contact the EU Office at an early stage if your are planning to submit an application.
ERC Advanced Grant 2026
The ERC Advanced Grant is aimed at excellent Principal Investigators that are established research leaders who want long-term funding to persue a ground-breaking, ambitious project. An ERC Advanced Grant Principal Investigator is expected to be an active researcher with a track record of significant research achievements. ERC Advanced Grants may be awarded up to € 2.5 million for a period of 5 years.
Deadline date for submission: 27.08.2026
ERC Plus Grant 2026
The ERC Plus Grant supports outstanding Principal Investigators who address a major scientific challenge. Applications for ERC Plus Grants should be for projects that could not be carried out with a regular ERC grant. Scholars at all career stages can apply for an ERC Plus Grant if they have an outstanding record of scientific achievement at the forefront of their field. ERC Plus Grants may be awarded up to € 7 million for a max. period of 7 years.
Deadline Date for Submission: 02.09.2026
Marie Skłodowska-Curie Postdoctoral Fellowship 2026
Postdoctoral Fellowships promote individual research projects for postdocs in Europe and abroad. Postdoctoral Fellowships are divided into European Fellowships and Global Fellowships and aim to enhance the career apportunities of Posdocs through international and inter-sectoral mobility.
Deadline date for submission: 09.09.2026
Marie Skłodowska-Curie Doctoral Networks 2026
Doctoral Networks are networks of European institutions with the purpose of training doctoral researchers in a structured manner to increase their competences in an international, interdisciplinary and intersectoral research and training programme.
Deadline date for submission: 14.11.2026
Mission Cancer 2026
The Work Programme for Mission Cancer has been finalised. The following topics will be open for submission in the Funding & Tenders Portal shortly:
- Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- Virtual Human Twin (VHT) Models for Cancer Research
- Earlier and more precise palliative care
- Improve the Quality of Life of older cancer patients
- Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
- Development of a research capacity building programme on cancer with and for Ukraine
- Microbiome for early cancer prediction before the onset of disease
Submission deadline: 15.09.2026
Advance Notice; Cluster Health 2027 (single stage)
The following 10 topics are announced in the Work Programme in the Cluster Health 2027 as single-stage calls:
- Addressing disabilities through the life course to support independent living and inclusion
- Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
- Tools and technologies to support health adaptation to climate change
- Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Tentative deadline for submission: 13.04.2027
Advance Notice; Cluster Health 2027 (two-stage)
The following 4 topics are announced in the Work Programme in the Cluster Health 2027 as two-stage calls:
- Innovative healthcare interventions for non-communicable diseases
- Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Portable and versatile Point-of-care diagnostics
Deadline for submission: 13.04.2027 (first stage), 22.09.2027 (second stage)
Advance Notice; Mission Cancer 2027 (single stage)
The following 6 topics are announced in the Work Programme for Mission Cancer as single stage calls:
- Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
- Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
- Leveraging functional genomics to reveal novel targets for cancer treatment
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
- Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Deadline for submission: 21.09.2027
Advance Notice; Cluster Health 2027/2 (single stage)
The following 3 topics are announced in the Work Programme in the Cluster Health 2027/2 as single stage calls:
- Advancing bio-printing of living cells for regenerative medicine
- Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Towards Artificial General Intelligence (AGI) for healthcare
Deadline for submission: 22.09.2027
Transition Open 2026
EIC Transition supports the late development stages and validation of novel technologies and the simultaneous development of a business model for future commercialisation.
Submission deadline: 16.09.2026
Pathfinder Challenges 2026
The EIC Pathfinder aims at identifying radical new technologies that have the potential to establish new markets. To achieve this aim, visionary and high-risk projects are promoted at an early development stage.
This call has two pre-defined challenges relevant to the healthcare sector:
- Biotechnology for Healthy Ageing
- DeepRAP: Deep Reasoning, Abstraction & Planning towards trustworthy Cognitive AI Systems
Smaller consortia (at least two eligible entities) or single applicants as well as larger consortia can apply.
Submission deadline: 28.10.2026.
Other EU Programmes: Current Calls
In addition to Horizon Europe, there are a number of other EU programmes that offer funding opportunities for research projects. Below you will find upcoming and open calls for other EU programmes.

Currently no open calls for proposals.
TRANSCAN-4 on cancer metablism
TRANSCAN-4 has announced its first Joint Transnational Call on the topic “Translational Research on Cancer Metabolism: Multidisciplinary Approaches for Diagnosis and Treatment.” Funding will support transnational collaborative projects consisting of up to six partners from at least three different countries participating in the call.
Deadline date for submission: 21.07.2026 (first stage)
Advance Notice; European Rare Diseases Research Alliance (ERDERA)
ERDERA will launch its Clinical Trial Call 2026, supporting multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.
The call particularly encourages proposals targeting “Paediatric rare diseases”, “Rapidly progressive rare diseases” and “Rare diseases lacking approved therapeutic options or with substantial residual unmet medical need despite existing treatments”.
Eligible interventions include “small molecules, including repurposed drugs”, “Advanced Therapy Medicinal Products (ATMPs) (provided the manufacturing process has been developed and validated under GMP conditions appropriate for Phase I/II use)”, “biologics and New Biological Entities (NBEs)” and “repurposed biologics”.
Deadline Date for submission: 10.09.26 (Expression of Interest), 29.10.26 (first stage)
Eurostars
The aim of Eurostars is to support European cooperation of small and medium-sized enterprises (SMEs) and project partners (large companies, universities, research organisations and other types of organisations) in research and development projects according to the „bottom-up principle“. Therefore, German research institutions only receive funding if a German SME is involved. In addition, the consortium must have a SME in the leading role.
Deadline for submission: 10.09.2026
Advance Notice; Innovative Health Initiative (IHI)
IHI has pre-announced its 13th call (two-stage). IHI calls fund large-scale European collaborative research and innovation projects. They are open to a wide range of stakeholders, e.g. from academia, large industry, small and medium-sized enterprises, hospitals, patient organizations, and regulatory authorities. The Call contains 3 topics:
- Topic 1: IHI European healthcare incubator network
- Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
- Topic 3: Decode the immuno-science of age-related mediated diseases
The publication of the draft call topics for Call 13 is expected in summer 2026, with the submission deadline in autumn 2026. Therefore, the versions released now may still change before the final call is published.
currently no open calls

EU Office
The EU Office of the Office of the Dean for Research at the Faculty of Medicine supports scientists in the application and handling of projects in the Framework Programme for Research and Innovation Horizon Europe of the European Union and in other EU and international funding programmes.
For further information and consultation, please contact the EU Liaison Officers.
EU Work Programmes and General Information
This section will provide you with links to current EU work programmes, useful templates and information sheets on several aspects of EU research funding and a link to an overview of countries associated to Horizon Europe.

-
Horizon Europe Main Work Programme 2021 – 2027
-
ERC Work Programme 2026
-
MSCA Work Programme 2026 – 2027
-
Cluster Health Work Programme 2026 – 2027
-
Missions Work Programme 2026 – 2027
-
EIC Work Programme 2026
-
Widening participation and strengthening the European Research Area Work Programme 2026 -2027
-
EU4Health Work Programme 2026
-
Templates for Time Sheets
Two Excel templates for time sheets (timesheet template daily and timesheet template monthly) were designed to avoid errors when calculating billable personnel costs in actual cost projects. The templates automatically mark the public holidays and convert the entered data into day equivalents. It is the responsibility of the user to adapt these independently to the individual processes of their organization. The documents are intended as non-binding assistance.
-
Annotated Template for „Information on Clinical Studies„
The annotated template is intended to assist applicants in filling out the template and to provide information and tips on what specific information is required.
The template must be completed for each Horizon Europe application if clinical studies or data collection and analysis of healthy or diseased individuals are planned within the project. Please note that the European Commission’s definition of clinical trials is described in the template.
-
Annotated Application Template for Research and Innovation Activities (RIA) and Innovation Activities (IA)
All applicants kindly take note: The network of National Contact Points has jointly released a handout regarding the application form for RIA and IA in Horizon Europe. This valuable document includes tips, tricks and explanations, as well as the most important answers to all questions related to the application and the use of the European Commission’s application template.
-
Annotated Model Grant Agreement (AGA) for Horizon Europe
The European Commission has published an Annotated Model Grant Agreement (AGA) for Horizon Europe.
-
The future of EU research and innovation funding from 2028 onwards
KoWi (Kooperationsstelle EU der Wissenschaftsorganisationen) provides key information on the preparation of the next EU Framework Programme for Research and Innovation – hereafter referred to as „FP10“.
-
HNN 3.0 – Supporting Tools
The transnational network of National Contact Points for Health (Health-NCP-Net 3.0, HNN 3.0) has created new “Supporting Tools” for applicants; e.g. “Health Impact Canvas Tool” and “Health Opportunities 2025 across Horizon Europe”.
-
Guidelines on the responsible use of generative AI in research
The EU Commission has put forward a set of guidelines to support the European research community in their responsible use of generative artificial intelligence. These guidelines offer guidance to researchers, research organizations and research funders to ensure a coherent approach across Europe.
-
Horizon Europe strategic plan 2025-2027 for research and innovation
The Commission has adopted the second strategic plan for Horizon Europe for the last three years of the program (2025-2027). The strategic plan forms the basis for the work programmes and call topics for Horizon Europe until 2027. The priorities for each cluster – including the Health cluster – are described in a separate chapter. The strategic plan also identifies the new European partnership “Brain Health”.
-
Handout on the Management of EU Projects
The Project Management Working Group of the “National Working Group (Bundesarbeitskreis) of EU Funding Advisors at German Universities and Colleges” has published a handout on the management of EU projects.
-
Information sheets on important topics in Horizon Europe
The National Contact Point for Health provides information sheets on important topics in Horizon Europe (e.g. application, rules of participation, open science) which are available for download. The information sheets briefly summarise the most important information on the respective topic relevant to the Cluster Health and funding opportunities for health projects.
-
How to manage your lump sum grants
This document is designed to help applicants submit their lump sum proposals and manage their lump sum grants in EU funding programmes.
Costs arising from applications to Horizon Europe may be reimbursed partially from funds provided by the Baden-Württemberg Ministry of Science, Research and the Arts (MWK).

Information on EU Programmes
The EU offers a wide range of programmes designed to support various sectors, including research, innovation and regional development. These programmes provide funding for individuals and collaborations across Europe. This section provides an overview of the main EU initiatives with which we can assist during the application process.
Horizon Europe is the current European Union’s framework programme for research and innovation with a budget of EUR 95.5 billion up to 2027. Horizon Europe offers a broad range of funding opportunities, from support for basic scientific research to application-oriented collaborative projects and market launch activities.
Horizon Europe is structured in three central pillars:
- Excellent Science
- Global Challenges and European Industrial Competitiveness
- Innovative Europe
An additional underlying pillar “Widening Participation and Strengthening the European Research Area” supports the entire programme and serves to optimise national research and innovation potential across Europe, thereby strengthening the European Research Area.

Source: factsheet “Horizon Europe – Investing to shape our future“ of the European Commission
The first pillar „Excellent Science“ primarily supports bottom up (individual) research at all levels and includes the European Research Council (ERC), Marie Skłodowska-Curie Actions (MSCA) and Research Infrastructures. ERC Advanced Grants fund established, active researchers with a track record of outstanding research contributions of 10 years or more. ERC Consolidator Grants fund promising researchers at the start of their careers as independent group leaders. These grantees have already established their own research group. ERC Starting Grants support young, innovative researchers who are setting up their own research groups. ERC Synergy Grants assemble two to four Principal Inverstigators who aim at implementing an ambitious, synergistic, inter- or transdisciplinary research programme. An ERC Proof of Concept funds researchers who are already ERC Grantees and who aim to use particular results from their grants by pre-commercial exploitation. MSCA Doctoral Networks are networks of European institutions with the purpose of training doctoral researchers in a structured manner to increase their competences in an international, interdisciplinary and intersectoral research and training programme.and MSCA Postdoctoral Fellowships. MSCA Postdoctoral Fellowships promote individual research projects of Postdocs at research institutions in Europe and abroad. They aim to enhance the career opportunities of Postdocs through international and inter-sectoral mobility.
The second pillar “Global Challenges & European Industrial Competiveness” comprises six thematic clusters, including the Cluster Health. This part of the programme provides funding for collaborative research, in which partners from different countries work together on a project. Applications can only be submitted in relation to topics within six different areas of intervention: 1) Health throughout the Life Course, 2) Environmental and Social Health Determinants, 3) Non-Communicable and Rare Diseases, 4) Infectious Diseases, including poverty-related and neglected diseases, 5) Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine, 6) Health Care Systems.
The third pillar “Innovative Europe” bundles together instruments with a focus on innovation and market uptake. These include, among others, the European Innovation Council (EIC). From basic research to the marketability of a product, this creates a wide range of participation opportunities.
Horizon Europe introduces missions for the first time in Pillar II to increase the effectiveness of funding by pursuing clearly defined targets. Five missions have been identified, one of which is the Mission Cancer. This mission addresses the understanding of cancer, prevention, diagnosis and treatment, quality of life and equal access to care. In addition, partnerships within the Cluster Health contribute to the implementation of Horizon Europe.
More information about Horizon Europe and the different programme parts can be found in the following links:
The EU4Health programme contributes to the EU’s objective of tackling long-term health challenges by building stronger, more resilient and more accessible health systems.
EU4Health is one of the main instruments to pave the way to a European Health Union. Established by Regulation (EU) 2021/522EN, EU4Health brings an EU added value and complements the policies of the Member States to pursue four general and ten specific objectives representing the areas of intervention:
- Improve and foster health
- Health promotion and disease prevention, in particular cancer
- International health initiatives and cooperation
- Protect people
- Prevention, preparedness and response to cross-border health threats
- Complementing national stockpiling of essential crisis-relevant products
- Establishing a reserve of medical, healthcare and support staff
- Access to medicinal products, medical devices and crisis-relevant products
- Ensuring that these products are accessible, available and affordable
- Strengthen health systems
- Reinforcing health data, digital tools and services, digital transformation of healthcare
- Enhancing access to healthcare
- Developing and implementing EU health legislation and evidence-based decision making
- Integrated work among national health systems
European Partnerships are means for cooperation between the European Commission, EU- Member States, the private sector and other stakeholders, to turn research results into socio-economic outcomes, and in turn, strengthen and adapt the European industry to major challenges such as digitisation and climate change.
These partnerships are instruments for aligning research, technology development and innovation with European political priorities and for creating synergies with national and regional programmes. European Partnerships come into place when the objectives of Horizon Europe can be better achieved by this instrument than through other activities in the framework programme. European Partnerships serve to complement European, national and regional initiatives. Horizon Europe is the most important framework for implementing these partnerships. The (financial) engagement of EU-Member States and the European industry is important.
There are now three distinctly different types of European Partnerships: Co-funded Partnerships (these bring together national and regional funding organizations and issue calls for proposals for transnational projects), Institutionalised Partnerships (for long-term commitment and a greater degree of integration; based on Article 185 or 187 of the Treaty on the Functioning of the European Union) and Co-Programmed Partnerships.
In addition to calls for proposals within Cluster Health, a number of European Partnerships provide additional funding opportunities in the field of health, which are supported by Horizon Europe funds. The following partnerships are either already in operation or are currently in preparation:
-
Innovative Health Initiative (IHI)
-
European & Developing Countries Clinical Trials Partnership (EDCTP)
-
European Partnership for the Assessment of Risk from Chemicals (PARC)
-
Fostering ERA for Health (ERA4Health)
-
Transforming Health and Care Systems (THCS)
-
European Partnership on Rare Diseases (EJP RD)
-
European Partnership for One Health/Antimicrobial Resistance (JPI AMR)
-
European Partnership Pandemic Preparedness
-
Joint Programming Neurodegenerative Disease (JPND)
-
ERA-NET NEURON
-
Antimicrobial Resistance (JPI AMR)
-
ERA-NET TRANSCAN
-
European Partnership for Personalised Medicine (EP PerMed)
-
Eurostars
The Interreg Upper Rhine Programme 2021-2027 funds cross-border collaborative projects in the metropolitan region Upper Rhine, namely the areas of Alsace, southern Palatine, Baden and the cantons of Northwestern Switzerland. The programme is supported by the European Fund for Regional Development (EFRD) and addresses a number of challenges that are common to all parts of the Upper Rhine region, such as mobility, climate change, cross-border public health issues as well as on reinforcing the research, development and innovation capacities in the region.
The Interreg Upper Rhine Programme is based on the principle of co-financing. Researchers interested in submitting proposals to open calls should note that own funding has to be provided. The programme’s share in the overall project costs will vary depending on the respective priority and the specific goals addressed by the call, but the recipient’s own funds should usually cover 50% of the planned project costs.
National Institutes of Health (NIH), US Federal Grants and Other International Programmes
Scientists are eligible to apply for grants of the National Institutes of Health (NIH) and other US-federal grants. Please note: The Medical Center – University of Freiburg can only participate in NIH funding or other US federal funded grants as a sub-awardee or sub-recipient (and not as main-awardee). Applying for external funding from US funding institutions often involves a great deal of administrative work and is subject to strict regulations. Therefore, please contact us as early as possible, if you are planning on applying for US federal grants.
Update from 18.09.2025: NOT-OD-25-155: NIH will no longer support traditional foreign subawards, but only foreign components that are structured as independent subprojects.
NIH’s most popular grant programme is the so-called Research Project Grant (R01), which supports a discrete, specified and circumscribed research project. R01 grants are generally awarded for 3-5 years. The maximum amount of funding is not specified for the R01, unless it is stated in the specific Funding Opportunity Announcement (FAO). Applications for the R01 grant can be submitted three times a year (February, June, October). Direct costs are reimbursed at rates up to 100%, whereas for the reimbursement of indirect costs, a current overhead of 8% has been set for foreign institutions.
Are you planning to apply for a US-Grant as sub-awardee?
Please contact us immediately and we will be happy to support you. Depending on the funder, an extensive procedure may be mandatory.
- We will ask you for completion of a disclosure form.
- We check formal aspects of your application.
- We solicit signatures.
- You obtain budget approval from your responsible employee of the third-party funding administration department.
Have you successfully acquired the grant? Congratulations!
Some administrative issues lie ahead before the contracts can be signed. Please contact us immediately and we will be happy to supportyou.
- We will ask you for completion of a disclosure form (if not already done)
- We check formal aspects of your award and/or agreement
- We will arrange – upon request – for a legal check of the regulations regarding intellectual property
- We solicit signatures
- You will contact the main awardee for their policy of “Financial Conflict of Interest” (FCOI).
Please note that you must adhere to the guidlines of the main awardee.
In addition, the Human Frontier Science Program (HFSP) is an international programme to promote excellent research in the life sciences. The programme supports interdisciplinary basic research elucidating the sophisticated and complex mechanisms of living organisms. The focus is on new collaborations between different fields, such as Biology, Physics, Mathematics, Chemistry and Engineering.
The following funding programmes are offered by the HFSP:
Research Grants: Research Grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries. Research grants are provided for teams of scientists from different countries who wish to combine their expertise in innovative approaches to questions that could not be answered by individual laboratories. Two types of grant are available: “Research Grants – Early Career” and “Research Grants – Program”. Both provide three years of support for 2 – 4 member teams. Awards are fixed sums dependent upon team size.
Postdoctoral Fellowships: The HFSP fellowship program supports proposals for frontier, potentially transformative research in the life sciences. Applications for high-risk projects are particularly encouraged. HFSP postdoctoral fellowships encourage early career scientists to broaden their research skills by moving into new areas of study while working in a new country. Two different fellowships are available: the Long-Term Fellowships and the Cross-Disciplinary Fellowships. There is only one competition per year for Fellowships. Firstly, applicants will be asked to submit a Letter of Intent from which the review committee will select the best proposals. In a second step, successful applicants will be invited to submit a Full Proposal.
Please refer the HFSP website for more information and deadlines.